Drug shortage
Fentanyl Citrate Injection · Hikma Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Apr 11, 2025
Key facts
| Generic name | Fentanyl Citrate Injection |
|---|---|
| Proprietary name | Fentanyl Citrate |
| Company | Hikma Pharmaceuticals USA, Inc. |
| Presentation | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) |
| Dosage form | Injection |
| Strength | 50 ug/1 mL |
| Status | Current |
| Reason for shortage | Other |
| Therapeutic category | Analgesia/Addiction Pediatric |
| Package NDCs | 0641-6025-10 |
| First posted | Dec 20, 2023 |
| Last updated | Apr 11, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: